Cancer Research

The silent progression of pancreatic ductal adenocarcinoma often renders medical intervention futile by the time a diagnosis is finally confirmed, yet a breakthrough study from the University of Michigan suggests that the secret to stopping this lethal disease lies in the very metabolic machinery

The biological resilience of pancreatic ductal adenocarcinoma (PDAC) has long earned it a reputation as the "impenetrable fortress" of oncology, maintaining a lethal grip on patients despite decades of intensive global research. While the discovery of ferroptosis—a specialized, iron-dependent form

The human immune system operates like a sophisticated military intelligence network, yet even the most advanced radar systems can fail if their power supply is severed at the source. For years, the global struggle against malignancy focused primarily on unmasking cancer cells, assuming that once

The biological machinery responsible for filtering waste sometimes malfunctions so catastrophically that routine metabolic processes turn into a source of systemic internal damage. Primary Hyperoxaluria represents a group of rare, inherited metabolic disorders that force the body into a state of

Ivan Kairatov stands at the intersection of biopharmaceutical innovation and clinical systems, bringing years of research and development experience to the conversation on modern healthcare delivery. As an expert in industry technology and therapeutic advancements, he has spent his career analyzing

The landscape of oncology is shifting from a one-size-fits-all approach toward a highly surgical precision, particularly in how we manage HPV-associated throat cancers. Ivan Kairatov, a veteran in the biopharmaceutical sector with a career dedicated to navigating the intersection of clinical